Timucuan Asset Management Inc. FL lessened its stake in Moelis & Company (NYSE:MC - Free Report) by 29.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,417,062 shares of the asset manager's stock after selling 581,453 shares during the quarter. Moelis & Company comprises 2.5% of Timucuan Asset Management Inc. FL's investment portfolio, making the stock its 16th biggest position. Timucuan Asset Management Inc. FL owned 1.80% of Moelis & Company worth $82,700,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of MC. MassMutual Private Wealth & Trust FSB raised its stake in Moelis & Company by 1,551.3% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 644 shares of the asset manager's stock worth $38,000 after acquiring an additional 605 shares in the last quarter. Versant Capital Management Inc increased its holdings in Moelis & Company by 1,460.8% in the 1st quarter. Versant Capital Management Inc now owns 796 shares of the asset manager's stock worth $46,000 after purchasing an additional 745 shares in the last quarter. NBC Securities Inc. bought a new position in Moelis & Company in the first quarter valued at about $59,000. GAMMA Investing LLC grew its holdings in shares of Moelis & Company by 38.9% during the first quarter. GAMMA Investing LLC now owns 1,632 shares of the asset manager's stock worth $95,000 after purchasing an additional 457 shares during the last quarter. Finally, New Age Alpha Advisors LLC bought a new position in Moelis & Company in the 1st quarter valued at approximately $107,000. Institutional investors and hedge funds own 91.53% of the company's stock.
Moelis & Company Stock Down 1.3%
NYSE MC traded down $0.97 on Friday, reaching $71.97. The company had a trading volume of 612,501 shares, compared to its average volume of 652,414. The stock has a market capitalization of $5.65 billion, a P/E ratio of 28.33 and a beta of 1.70. The company's fifty day moving average is $69.28 and its 200 day moving average is $62.50. Moelis & Company has a 52-week low of $47.00 and a 52-week high of $82.89.
Moelis & Company (NYSE:MC - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The asset manager reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.32 by $0.21. The firm had revenue of $365.38 million during the quarter, compared to the consensus estimate of $269.57 million. Moelis & Company had a return on equity of 42.72% and a net margin of 14.31%.The business's revenue for the quarter was up 38.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.18 EPS. On average, research analysts expect that Moelis & Company will post 2.97 EPS for the current year.
Moelis & Company Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Monday, August 4th will be paid a dividend of $0.65 per share. This represents a $2.60 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date is Monday, August 4th. Moelis & Company's dividend payout ratio is presently 102.36%.
Wall Street Analysts Forecast Growth
MC has been the subject of a number of recent research reports. Zacks Research upgraded Moelis & Company from a "hold" rating to a "strong-buy" rating in a report on Monday, August 18th. Keefe, Bruyette & Woods upped their target price on Moelis & Company from $69.00 to $89.00 and gave the company an "outperform" rating in a report on Monday, July 14th. The Goldman Sachs Group upped their target price on Moelis & Company from $56.00 to $63.00 and gave the company a "neutral" rating in a report on Thursday, May 15th. Wells Fargo & Company boosted their price target on Moelis & Company from $50.00 to $64.00 and gave the company an "equal weight" rating in a research note on Friday, July 11th. Finally, Morgan Stanley raised Moelis & Company from an "underweight" rating to an "overweight" rating and boosted their price target for the company from $42.00 to $68.00 in a research note on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Moelis & Company has a consensus rating of "Hold" and an average target price of $66.00.
View Our Latest Report on Moelis & Company
Insiders Place Their Bets
In other Moelis & Company news, Director Kenneth Shropshire sold 2,615 shares of Moelis & Company stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $72.52, for a total transaction of $189,639.80. Following the completion of the transaction, the director owned 7,109 shares of the company's stock, valued at $515,544.68. The trade was a 26.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, General Counsel Osamu R. Watanabe sold 6,340 shares of Moelis & Company stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $72.64, for a total value of $460,537.60. Following the transaction, the general counsel directly owned 131 shares of the company's stock, valued at $9,515.84. The trade was a 97.98% decrease in their position. The disclosure for this sale can be found here. 6.40% of the stock is owned by company insiders.
About Moelis & Company
(
Free Report)
Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments.
Featured Articles

Before you consider Moelis & Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.
While Moelis & Company currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.